Albany, NY -- (SBWIRE) -- 10/16/2020 -- Global Ventilator Accessories Market: Overview: The report details an exhaustive account of the global ventilator accessories market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2016 to 2024. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global ventilator accessories market, as well for those who intend to newly establish themselves in this environment.

Global Ventilator Accessories Market: Market Potential and Restraints

Rapid technological advancements occurring in the field of medical device manufacturing is majorly driving the global ventilator accessories market to experience tremendous growth. Increasing number of cases of chronic respiratory disorders among people all over the world too is contributing towards a rise in revenue generated by this market. Moreover, with a surging geriatric population, a high prevalence of these diseases exists, thereby causing a notable requirement of ventilators and associated accessories to exist. The ventilator accessories market is being driven with increasing sales of portable and mechanical ventilators.

Furthermore, with a rise in the number of hospitals and other healthcare centers, a high demand for ventilator systems exists, consequently propelling the market to attain splendid growth. Growing per capita income, extensive R&D investments in the healthcare industry by top market players, rising demand for advanced front-line technologies, and expansion of private hospitals and rehab-centers in remote areas are major factors driving growth of the ventilators accessories market globally.

However, high costs required to set up procurement of ventilators and their accessories along with relevant technologies, as well as expensive research and development activities for the same is greatly hampering the market. Lack of trained professionals in underdeveloped and remote areas who can use the ventilator systems and accessories is another significant factor hindering the global ventilator accessories market. Nevertheless, the picture is soon expected to change as numerous service providers companies are gradually introducing cost-effective ventilator accessories.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15299

Global Ventilator Accessories Market: Geographical Outlook
Geographically, the global ventilator accessories market is spread acr
oss North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of all these, North America is the largest regional segment of the ventilator accessories market, followed by Europe. Apart from these regions, Asia-Pacific also depicts an enhanced growth rate in the market to exist during the forecast period. The rate of efficiency is mainly attributed to the geriatric population worldwide, rising incidences of cardio-vascular & respiratory diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry worldwide. These regions are expected to generate the fastest growth rates potentially.

Request for Analysis of COVID19 Impact on Ventilator Accessories Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=15299

Global Ventilator Accessories Market: Competitive Landscape

This market showcases the presence of a highly competitive vendor landscape, owing to most players continuously trying to outgun their rivals. Many businesses are focusing on introducing new devices on a frequent basis, as well as improving technological efficiency. Reducing device costs to benefit ease of accessing relevant healthcare services and treatments is another area where many businesses in the global ventilator accessories market are striving to succeed.

With more players expected to enter the market in the next few years, the competition is projected to become more intense. Draegerwerk AG & Co. KGaA, GE Healthcare Ltd., Siemens Healthcare, ResMed Inc., Fisher &, Paykel Healthcare Corp. Ltd., Hamilton Medical AG, Invacare Corp., CAS Medical Systems Inc., Nihon Kohden Corp., Nonin Medical Inc., Criticare Systems Inc., Spacelabs Healthcare Inc., Nellcor Puritan Bennett LLC, ALARIS Medical Systems Inc., Criticare Systems Inc., Masimo Corp., and Welch Allyn Inc., are key players operating in the global ventilator accessories market.

Pre book Ventilator Accessories Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=15299

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/16/2020 -- Primary Immunodeficiency Market: Introduction

Transparency Market Research has published a new report titled, 'Global Primary Immunodeficiency Market '. According to the report, the global primary immunodeficiency market was valued at US$ 5.7 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2028. The primary immunodeficiency disorders (PIDs) are clinically heterogeneous disorders, the majority of which arise from genetic defects in immunologically relevant genes. Primary immune deficiencies are present in a heterogeneous manner, and a high index of suspicion is required to diagnose primary immune deficiencies. Any patient with a suspected or proven primary immunodeficiency disorder (PID) should be referred to the care of a clinical immunologist. Immune dysregulation phenotypes of PID are commonplace and include multiorgan autoimmunity, malignancy (particularly hematological), and autoinflammatory pathology such as periodic fever syndromes.

In terms of type, the global primary immunodeficiency market has been segmented into antibody deficiency, cellular deficiency, and innate immune. Antibody deficiency has been categorized into agammaglobulinaemia, common variable immune deficiency, selective IgA deficiency, IgG subclass deficiency, and others. Cellular deficiency has been classified into Ataxia Telangiectasia, hyper IgM syndromes, Wiskott-Aldrich syndrome, DiGeorge syndrome, and others. Innate immune has been split into complement deficiencies, hyper IgE syndrome, and others. The antibody deficiency segment captured the largest market share in 2019. The segment is expected to expand at the highest CAGR during the forecast period, owing to rise in need and demand for diagnosis by patients.

Request for Brochure-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3137

Based on treatment type, the global primary immunodeficiency market has been divided into immunoglobuline replacement therapy, antibiotic therapy, stem cell and gene therapy, and others (vaccines, nutritional supplements, and others). The immunoglobuline replacement therapy segment captured the largest market share in 2019. The segment is expected to expand at the highest CAGR during the forecast period due to increase in need and demand for diagnosis by patients.

Primary Immunodeficiency Market: Prominent Regions

North America held a major share of the global primary immunodeficiency market in 2019. Highly structured healthcare industry, presence of key players, and growth strategies of these players are the major factors driving the market in the region. Rise in awareness about benefits of procedures and increase in healthcare expenditure also contribute to the growth of the market in North America. Asia Pacific held the second largest share of the global primary immunodeficiency market in 2019. Growth of the primary immunodeficiency market in the region can be attributed to rise in prevalence of chronic diseases and well-developed health care sector in the region. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. Increase in the number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases which ultimately lead to regular checkup and diagnosis, are factors anticipated to fuel the growth of the primary immunodeficiency market in the region.

Request for Analysis of COVID19 Impact on Primary Immunodeficiency Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3137

Primary Immunodeficiency Market: Key Players

Key players are expanding their footprint to strengthen their position in the global primary immunodeficiency market. Gradual increase in incidence of primary immunodeficiency diseases globally offers lucrative opportunities to key players to increase their share in the primary immunodeficiency market. Hence, manufacturers are engaging in new product development, collaborations, and distribution to gain market share. Leading players operating in the global primary immunodeficiency market include Shire plc, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc., Biotest AG, Sanquin, and LFB SA.

Buy Primary Immunodeficiency Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=3137

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/15/2020 -- Ambulance Services Market: Introduction

Transparency Market Research has published a new report on the ambulance services market. According to the report, the global ambulance services market was valued at ~US$ 39 Bn in 2018. The ambulance services market is expected to expand at a CAGR of ~4% during the forecast period of 2019 to 2027.

Ambulances help rescue injured or medically ill patients by transporting them to medical treatment centers. Established and new players are launching new and advanced ambulances and services to provide high level of comfort and medical services to patients. This is expected to drive the ambulance services market. For example, in 2019, in India, the State Government Health Department of Odisha launched the first ever boat ambulance service at Batighar in Kendrapara district. In Odisha, a large number of riverside villagers still depend on passenger boats, which are not available at night. This boat ambulance service helps them during medical emergencies. The government is planning to launch five more such boats at end of this year.

In terms of mode of transport, the ground ambulances segment held a major share of the global ambulance services market in 2018. This segment is likely to maintain its dominance during the forecast period. The ground ambulances segment is projected to be the most attractive segment during the forecast period. It is the most widely used method of emergency medical service, and is anticipated to offer lucrative opportunities, especially in developing countries.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2347

Based on equipment, the basic life support (BLS) segment accounted for a major share of the global ambulance services market. This segment is projected to grow at a moderate CAGR during the forecast period. Medical services are provided by emergency medical practitioners and partially-trained personnel in BLS ambulances. BLS ambulance services are usually provided to patients with complex fractures, medical or surgical patients being discharged for home or some sub-acute care facilities, and psychiatric patients. Increase in the number of surgeries, globally, is likely to fuel the growth of the segment, as BLS ambulance services would be needed to transport patients from hospitals to homes and vice-versa. Patients who have undergone surgery and do not require medical monitoring are advised to avail BLS ambulance services, as personal vehicle transport may create post medical surgery complications (because of their built). This would further drive the demand for BLS ambulance services.

Global Ambulance Services Market: Prominent Regions

North America held a major share of the global ambulance services market in 2018. This can be attributed to increase in the adoption of advanced treatment approaches, and favorable reimbursement policies due to increase in geriatric and obese populations that are more susceptible to various chronic and acute diseases.
Europe held the second-largest share of the global ambulance services market in 2018. Major markets in Europe include Germany, France, the U.K., Spain, and Italy. According to the European Commission (EC), around 100 million people in Europe suffered from one or more physical disability in 2015, and this number is likely to increase during the forecast period due to rise in the incidence of accidents. This is likely to increase the demand for ambulances for transportation to hospitals. Therefore, the ambulance services market is anticipated to witness strong growth in Europe during the forecast period.

Request for Analysis of COVID19 Impact on Ambulance Services Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2347

Asia Pacific accounted for a significant share of the global ambulance services market in 2018, and this market is expected to grow at rapid pace during the forecast period. Major markets in Asia Pacific include Australia & New Zealand, India, China, and Japan. Japan is a mature market for ambulance services due to the presence of various government rebates and favorable reimbursement policies for availing ambulance services by patients. The National Health Insurance (NHI) and Employees' Health Insurance (EIS) Systems of Japan help provide reimbursements for the ambulance services fees entailed. Economic development in various countries such as India and China has led to rise in the disposable income of the population, which, in turn, has increased the affordability for various medical services by the patient population.

Global Ambulance Services Market: Key Players

Key players are expanding their footprint to strengthen their position in the global ambulance services market. Increase in the patient population and rapidly increasing number of trauma cases offer lucrative opportunities to key players to increase their share in the ambulance services market. Manufacturers engage in strategic acquisitions, collaborations, and distribution to expand their market share in the ambulance services market.
Prominent players operating in the global ambulance services market are Acadian Ambulance Service, Inc., Air Methods Corporation, Dutch Health B.V., Envision Healthcare Corporation, Falck A/S, London Ambulance Service NHS Trust, Air Medical Group Holdings, Inc., Scandinavian AirAmbulance, and Lufttransport AS.

Buy Ambulance Services Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=2347

Global Ambulance Services Market: Segmentation

Ambulance Services Market by Mode of Transport
-Ground Ambulances
-Air Ambulances
-Water Ambulances
Ambulance Services Market by Equipment
-Basic Life Support (BLS)
-Advanced Life Support (ALS)
Ambulance Services Market by Service
-Emergency
-Non-emergency

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/15/2020 -- Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the major factors expected to drive the global medical education market from 2019 to 2027.

Increase in Number of Medical Schools to Drive the Medical Education Market

-Globalization has had an unprecedented effect on medical education across the world. The global medical education market is expected to expand at a CAGR of more than 4% from 2019 to 2027.

-A number of trends have been observed in the medical education market. Increase in privatization of medical schools, rise in the number of medical schools, surge in the number of students seeking medical education, and migration of medical students are all contributing to the growth of the global medical education market.
-New collaborative models between medical schools across the world have further fuelled the medical education market. Emerging countries are investing in healthcare infrastructure in order to improve the quality of services and expand the access of services, which would require more medical professionals. This is likely to fuel the global medical education market.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=517

Asia Pacific Medical Education Market to Expand at a Rapid Pace

-North America held a major share of the global medical education market in terms of revenue in 2018, and is projected to retain its position during the forecast period. The presence of top medical schools, high fee structure, and increasing presence of international students have all led to a large market share for the region in the global medical education market.
-According to the World Directory of Medical Schools, around one-third of medical schools are located in one of the five countries (India, the U.S., China, Brazil, and Pakistan). Over 10 countries account for nearly half of all medical schools in the world.
-Some of the most recognized medical schools such as Johns Hopkins School of Medicine, University, Stanford University School of Medicine, and Harvard Medical School are located in the U.S. High disposable income and well-developed healthcare infrastructure have contributed to North America's large share in the global medical education market.
-Europe is anticipated to be the second-largest medical education market in terms of share and revenue during the forecast period. Developed healthcare infrastructure and opening of new medical schools are driving the medical education market in Europe.
-The medical education market in Asia Pacific is anticipated to expand at a CAGR of more than 4% during the forecast period. The presence of countries such as China and India with rapidly number increasing medical schools and medical students is attributed to strong market growth in the region. According to the World Directory of Medical Schools, India had the most recognized medical schools, followed by Brazil and China, in 2016.

Request for Analysis of COVID19 Impact on Medical Education Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=517

Johns Hopkins School of Medicine, Stanford University School of Medicine, and Siemens Healthineers to Lead the Global Medical Education Market

The report provides the profiles of leading players operating in the global medical education market. These include Gundersen Health System, GE Healthcare Institute, American College of Radiology, Healthcare Training Institute, New Jersey, Olympus America, TACT Academy for clinical training, Zimmer Biomet Institute, Harvard Medical School, Johns Hopkins School of Medicine, Stanford University School of Medicine, Apollo Hospitals, CAE Healthcare, and Siemens Healthineers.

-Zimmer Biomet Institute provides online training medical education programs through Zimmer Biomet Institute Network (zbinetwork) (zbinetwork.com). Zbinetwork is an online interactive platform that offers healthcare professionals with mobile applications to access and learn about different products, procedures, tutorials, and related technologies.
-The Olympus Academy offers various training programs and courses on endoscopy devices for nurses, such as endoscope reprocessing specialist training (ERST), surgical scopes reprocessing & handling training (SSRHT), endoscopic ultrasound (EUS) course, endoscope & endobronchial ultrasound (EUS/EBUS) course, endoscopic retrograde cholangiopancreatography (ERCP), and Surgical Certified Endoscope Reprocessing Trainer (Train the Trainer).
-The launch of new medical courses, introduction of new subspecialties, and escalating fee structure of medical schools are all expected to drive the global medical education market during the forecast period.

Buy Medical Education Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=517

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/15/2020 -- The global audiological devices market was valued at US$ 8.7 Bn in 2017. It is projected to expand at a compound annual growth rate (CAGR) of 5.0% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled "Audiological Devices Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026". The report suggests that increase in the geriatric population and number of hearing impairment cases is expected to propel the audiological devices market in the near future. Europe is expected to dominate the global market, owing to the high geriatric population, rise in patient population, and increase in number of technological advances. The market in Asia Pacific is expected to expand at a CAGR of 6.5% during the forecast period, due to the increasing geriatric population, rising awareness, and growing patient population cases in the region. Moreover, research and development activities and initiatives by governments in the healthcare sector are anticipated to further boost the market in Asia Pacific.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1287

Value added features in audiological devices is to fuel global market expansion

The global audiological devices is expected to be potentially driven by value added features offered by various audiological devices in order to provide appropriate diagnosis, efficient treatment, generating positive outcomes, and suitable medical aid and care. According to WHO, in 2018, worldwide, approximately 466 million people had disabling hearing loss, and among them, 34 million were children. It is anticipated that by 2050, around 900 million people would have disabling hearing loss. Key players offering audiological devices in the market are providing value added features such as launching products with more technological advancements, more efficacy, and technical features, offering effective care, thus providing an enhanced product as compared to existing products in the market. Therefore, companies are focusing on research and developmental activities, thereby providing value added features in audiological devices.

Cochlear implants are projected to be highly lucrative product type

For individuals with mild to moderate hearing loss, traditional hearing aids are prescribed by medical professionals. These are less expensive and offer more flexibility; however, these instruments don't process sound like cochlear implants. Cochlear implants are utilized for severe hearing impairment, and people who cannot be assisted with hearing aids. Cochlear implants can be used by both adults and children. Patient population with profound hearing loss or deafness have sensorineural hearing loss, in which there is damage to the minuscule hair cells in the inner ear, in a part called the cochlea. Hearing aids, are used to make sounds louder, while cochlear implants are used to simulate the function of inner ear's (cochlea) damaged parts and transmit sound signals to the brain. According to The Ear Foundation, there are approximately 14,000 implant users in the U.K., and around 700 adults and 550 children are implanted every year.

Request for Analysis of COVID19 Impact on Audiological Devices Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1287

Meniere's disease and otitis media lead the audiological devices market

The report offers the detailed segmentation of audiological devices in terms of diseases, into otosclerosis, Meniere's disease, acoustic tumors, otitis media, and others. Meniere's disease and otitis media disease segments are projected to account for a leading share of the market during the forecast period. Increasing geriatric population, rising hearing loss among both children and adults, and increasing prevalence and incidence cases of these diseases are key factors that are expected to propel the audiological devices market. Moreover, extensive research & developmental activities and increasing interest of scientists in research for treatment of these diseases enhance their lead in the market.

Clinics segment is estimated to dominate the audiological devices market

In terms of end-user, the clinics segment held a leading share of the global audiological devices market in 2017. It is anticipated to gain market share by the end of 2026 and expand at a CAGR of 5.0% during the forecast period. Increasing number of audiology clinic visits by patients, hearing loss or deafness cases, injuries, and genetic disorders, congenital defects, increasing audiologists number, or ENT specialists boost the clinics segment of the global audiological devices market. Furthermore, rising number of clinics and increasing network of key players with clinics and medical professionals & related care have led the clinics segment to hold a prominent share of the global market

Buy Audiological Devices Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=1287

Development of technologically advanced devices and geographic expansion are key strategies adopted by leading players

The report also provide profiles of leading players functioning in global audiology devices market. William Demant Holding A/S, GN Store Nord A/S, Sonova, WIDEX A/S, Sivantos Pte. Ltd., Medtronic, Starkey, Audina Hearing Instruments, Inc., AUDITDATA, and Nurotron Biotechnology Co. Ltd. are major leading players operating in the global audiological devices market and account for significant market share. Companies functioning in the audiological devices industry are focused on strengthening their geographic presence through strategic acquisitions, collaborations, and mergers with audiological devices market players in respective domains and geographies. Strong progressive research and development activities and increasing high tech advancements are key strategies adopted by major players to consolidate their position in the global audiological devices market.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/14/2020 -- Global Interventional Pulmonology Market: Overview

Interventional pulmonology is a branch of medical science that deals with minimally invasive medical procedures carried out under image guidance by interventional pulmonologists for the diagnosis, treatment, and palliation of different types of pulmonary disorders. Interventional pulmonology procedures involve usage of different image guided techniques such as computed tomography, fluoroscopy, and ultrasound to diagnose and treat the specific site affected with pain or cancer. Interventional pulmonology procedure is most commonly performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages such as quicker recovery, shorter hospital stay, minimal side effects, and more precise and accurate treatment compared to other therapeutic procedures.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61695

Global Interventional Pulmonology Market: Trends and Opportunities

The global interventional pulmonology market is primarily driven by high prevalence and increase in incidence rates of lung cancer across the world. Lung cancer is one of the leading causes of death globally. According to the World Health Organization (WHO), lung cancer accounted for 2.9 million deaths in 2018. Moreover, increase in incidence rates of chronic obstructive pulmonary disorders, airway strictures, and amyloidosis across the world is projected to boost the growth of the global interventional pulmonology market during the forecast period. Furthermore, advantages of minimally invasive surgical procedures, technological advancements in interventional pulmonology, and increase in government funding for oncology procedures are anticipated to fuel the growth of the global market during the forecast period.

Global Interventional Pulmonology Market: Segmentation

The global interventional pulmonology market can be segmented based on procedure, indication, and region. In terms of procedure, the market can be divided into tumor debulking, endobronchial brachytherapy, endobronchial stenting, photodynamic therapy, and others. Tumor debulking procedure refers to the removal of tumor growing within the airway lumen endoscopically either by heating, freezing, vaporizing, or simply by resecting the tumor by with biopsy. Different techniques such as endoscopic laser resection, electrocoagulaion, and cryotherapy have been used for the removal of the tumor. Endobronchial brachytherapy procedure involves administration of high dose radiotherapy through the catheter at the surgical site in the airway. Endobronchial stenting procedure involves the placement of stents to relieve the symptoms of airway obstruction. Different types of metallic as well as silicone stents are currently available in the market and demand for these stents is increasing. Based on indication, the global interventional pulmonology market can be classified into lung cancer, chronic obstructive pulmonary disorder (COPD), carcinoid tumors, airway strictures, amyloidosis, tuberculosis, and others. The lung cancer segment is projected to dominate the global market from 2018 to 2026 owing to significant burden of lung cancer across the globe.

Request for Analysis of COVID19 Impact on Interventional Pulmonology Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61695

Global Interventional Pulmonology Market: Regional Analysis

Geographically, the global interventional pulmonology market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are anticipated to account for major shares of the global market due to large population afflicted with chronic lung cancer, chronic obstructive pulmonary disorders, airway stricture, and airway related disorders. Moreover, significant adoption of minimally invasive surgeries for the effective management of airway disorders, well-established health care infrastructure, and early adoption of technologically advanced interventional pulmonology products are likely to fuel the growth of the market in these regions during the forecast period. The interventional pulmonology market in Asia Pacific is expected to expand at a high CAGR during the forecast period due to rise in prevalence of cancer in the highly populous countries of India and China, rapidly changing health care systems, various government initiatives to improve overall health care, and increased per capita health care expenditure. Moreover, rise in investments by leading global interventional pulmonology devices companies in the region is likely to contribute to the growth of the market in Asia Pacific during the forecast period.

Pre book Interventional Pulmonology Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=61695

Global Interventional Pulmonology Market: Companies Mentioned

Key players operating in the global interventional pulmonology market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson & Johnson), Merit Medical Systems, Inc., Eckert & Ziegler BEBIG, Varian Medical Systems, Inc., HealthTronics, Inc., Roechling Group, Pulmonx, Inc., EndoChoice, Inc., ENDO-FLEX GmbH, and Karl Storz.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/14/2020 -- Hepatitis Test Kits Market: Introduction

-Hepatitis can be defined as inflammation of the liver, which can be self-limiting or could progress to cirrhosis, fibrosis, or liver cancer. Hepatitis is commonly caused by hepatitis virus. However, the other causes of hepatitis include autoimmune hepatitis and hepatitis that occurs due to secondary causes, including drugs, medications, alcohol, and toxins.
-Hepatitis can be classified into five types: A, B, C, D, and E, which are caused by different viruses. Hepatitis A & E are caused due to ingestion of contaminated water and food. Hepatitis B, C, and D are caused because of parenteral contact with infected body fluids.
-Hepatitis A is an acute short-term disease, whereas hepatitis B, C, and D are likely to be chronic and ongoing. Hepatitis E is considered an acute infection and is known to be particularly dangerous in pregnant women. The common symptoms of acute hepatitis include flu-like symptoms, fatigue, pale stool, and dark urine, loss of appetite, unexplained weight loss, and abdominal pain.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76555

Key Drivers and Restraints of Global Hepatitis Test Kits Market

-The global hepatitis test kits market is driven by rise in prevalence of hepatitis. According to the WHO, an estimated 20 million HEV infections are reported globally every year, leading to around 3.3 million symptomatic cases. Rise in prevalence of hepatitis E increases demand for diagnostic kits, which in turn boosts the growth of the global market.
-Lack of sanitation in emerging countries increases the prevalence of hepatitis A & E, which in turn drives demand for hepatitis diagnostic test kits. According to the WHO, over 2.4 billion people are still living without sanitation facilities, including 946 million people who defecate in the open. Moreover, rural areas are home to 7 out of 10 people without access to toilets and 9 out of 10 people who defecate in the open. The regions marked as high risk are rural areas in Asia and Africa, which increases the risk of HEV infections.
-Certain forms of hepatitis are asymptomatic, which could have a negative impact on the global diagnostic test kits market. According to a study, seroprevalence of HEV is significantly high in certain developed countries such as Germany; however, most HEV infections are asymptomatic and there is a relative rarity of clinically diagnosed infections.

Request for Analysis of COVID19 Impact on Hepatitis Test Kits Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76555

North America to Lead Global Hepatitis Test Kits Market

-In terms of region, the global hepatitis test kits market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
-North America dominated the global hepatitis test kits market in 2018, owing to strong presence of leading market players, increase in product approvals, well-established health care infrastructure, and high prevalence of hepatitis associated with lifestyle disorders
-Europe was the second largest market for hepatitis test kits in 2018, followed by Asia Pacific. Asia Pacific is projected to be the fastest growing market for hepatitis test kits, followed by Latin America and Middle East & Africa. Rise in focus of governments of countries in Asia on enhancing the health care facilities, increase in focus of the market players on leveraging the opportunities offered by the emerging markets, growing medical tourism leading to the spread of hepatitis virus, and rise in prevalence of hepatitis A and E owing to the lack of sanitation contribute to the growth of the hepatitis test kits market in Asia Pacific.

Pre book Hepatitis Test Kits Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=76555

Key Players Operating in Global Hepatitis Test Kits Market

Leading players in the global hepatitis test kits market are:
-Hoffmann-La Roche Ltd.
-QIAGEN
-Bio-Rad Laboratories, Inc.
-Hologic, Inc.
-Abbott Laboratories
-Grifols, S.A.
-Biokit S.A. (A Werfen Company)
-SD BioSensor Inc.
-Beijing Wantai Biological Pharmacy
-Mikrogen GmbH
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/14/2020 -- Dermal Regeneration Matrix Device Market: Introduction

-Dermal Regeneration Matrix Device is used for treating certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound. Utilization of dermal regeneration matrix devices in wound healing offers numerous benefits in terms of stimulating tissue growth and ensuring relief from various injuries. Furthermore, these devices reduces the occurrence of infection at the wound sites and minimize irritation. Dermal regeneration matrix is gaining importance, which in turn is likely to drive the market.

Key Drivers and Restraints of Global Dermal Regeneration Matrix Device Market

-Chronic wounds have created a significant socioeconomic impact. Chronic wounds generally take longer time to heal and require advanced wound care therapies. Diabetic ulcers are becoming more common due to increased incidence of both Type I and maturity-onset diabetes in developed economies across the world. According to a research done by National Center for Biotechnology Information (NCBI), global prevalence of diabetic foot ulcer was 6.3%, higher in males (4.5%) as compared to that in females (3.5%). For instance, NCBI estimated that globally, every 30 seconds one leg is amputated due to diabetic foot ulcer. Lifetime risk of developing diabetic foot ulcer among the diabetic population is 25%. Thus, increasing prevalence of diabetic foot ulcer is expected to boost the global dermal regeneration matrix device market.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76543

-A large under-addressed population of patients suffering from chronic wounds exists, especially in emerging countries. Increase in per capita income of people in these countries is fueling the adoption of advanced wound care technologies. Better access to advanced wound care and increase in awareness about the cost-effectiveness of advanced wound care therapies have boosted the momentum shift toward these solutions and products. Rate of adoption of solutions and products, such as dermal regeneration matrix, among health care providers is increasing, which in turn is estimated to drive the global dermal regeneration matrix device market during the forecast period.
-Dermal regeneration matrix devices help in the reduction of healing and complications associated with burn injuries, ischemia, trauma, surgeries, and skin disorders. Dermal regeneration matrix devices are commercially available to treat chronic wounds. A large number of market players are engaged in the development of dermal regeneration matrix devices. For instance, in January 2016, Integra LifeSciences Corporation received USFDA approval for its product, Omnigraft Dermal Regeneration Matrix, to treat diabetic foot ulcers that last longer than six weeks and do not involve exposure of the joint capsule, tendon, or bone.

Request for Analysis of COVID19 Impact on Dermal Regeneration Matrix Device Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76543

Asia Pacific to Lead Global Dermal Regeneration Matrix Device Market

-Europe is a mature market for diabetic foot ulcer treatment; therefore, the market in the region has been stagnant. The growth rate witnessed by the market in Europe has been sluggish due to a well-established network of major market players, which creates relatively fewer opportunities for growth and business expansion for new market entrants. However, rise in geriatric population and favorable health care reimbursement regulations are likely to drive the market in the region during the forecast period.
-The dermal regeneration matrix device market in several countries in Asia, including Japan, India and China, is untouched or significantly underpenetrated as compared to that in countries in North America and Europe. This is primarily due to a lack of access to dermal regeneration matrix devices in these countries and low level of awareness. These markets offer immense opportunities for the dermal regeneration matrix device market on account of factors such as presence of a large potential population base coupled with continuous economic development witnessed in several countries across Asia. Geographic expansion by major global players in Asia Pacific through distribution and licensing agreements with local distributors and increasing prevalence of diabetes in the region are likely to fuel market in Asia Pacific during the forecast period.

Pre book Dermal Regeneration Matrix Device Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=76543

Key Players Operating in Global Dermal Regeneration Matrix Device Market

Manufacturers in the global Dermal Regeneration Matrix device market are increasingly investing in research and development of new and innovative techniques to manufacture advanced products for screening. These players are also focused on offering highly efficient and reliable products.

Leading companies operating in the global dermal regeneration matrix device market are:
-Integra LifeSciences
-MiMedx
-Stratatech (Mallinckrodt)
-Theracell
-Organogenesis
-KCI Licensing, Inc.
-Symatese
-Acell
-Kerecis
-Japan Tissue Engineering Co., Ltd.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/14/2020 -- Global Lyme Disease Therapeutics Market: Overview

-Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes.
-If left untreated, these symptoms may worsen and can lead to partial or complete loss of facial movement, severe headache, stiffness in the neck, joint pain and swelling, irregular heartbeats, etc. The patient may also, sometimes, develop tingling or shooting pain in the extremities. If the disease is diagnosed at an early stage, it can be treated with antibiotics. However, if left unattended, it may affect the heart, the joints, and the central nervous system, ultimately leading to death.
-The global Lyme disease therapeutics market is projected to expand at a significant pace during the forecast period, owing to rise in the rate of incidence of Lyme disease across the globe and continuous R&D activities for the development of vaccines for Lyme disease.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76335

Key Drivers of Global Lyme Disease Therapeutics Market

-Unmet medical needs with respect to the treatment of Lyme disease, led by variations in Borrelia burgdorferi genotypes, limit complete cure of the disease. Innovations are underway in the pharmaceutical industry in the area of vaccine candidates. This is expected to increase the rate of prevention of Lyme disease in the near future. The continuing need for reinventing the drug pipeline, led by bacterial mutation and resistance, serves as an opportunity for the global Lyme disease therapeutics market.
Restraints of Global Lyme Disease Therapeutics Market
-Pathways to the approval for Lyme disease drugs from regulatory bodies have become confusing, generally infeasible, and questionably irrelevant to patients and providers over a period of time. Additionally, scientific and regulatory challenges significantly increase the cost of and time required for drug development, which greatly worsens economic disadvantages of Lyme disease drugs.
-In view of the urgency of bacterial drug resistance and the capacity of targeted disease to change rapidly over time, regulatory bodies are not in favor of revision and streamlining of the anti-bacterial drug development and approval process

Request for Analysis of COVID19 Impact on Lyme Disease Therapeutics Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76335

North America to Account for a Major Share of Global Lyme Disease Therapeutics Market

-North America is likely to dominate the global Lyme disease therapeutics market during the forecast period, due to high rate of incidence of Lyme disease and high awareness about and adoption of new diagnostic methods in the region. According to the Centers for Disease Control and Prevention (CDC), Lyme is one of the most common infectious diseases in North America and around 300,000 people in the region get infected with the disease every year.
-The Lyme disease therapeutics market in Asia Pacific is expected to expand at a significant CAGR during the forecast period, owing to rise in the demand for Lyme disease diagnostics in developing nations in the region. Moreover, rise in government and private initiatives to spread awareness regarding bacteria-borne health conditions are anticipated to drive the market in Asia Pacific during the forecast period.

Pre book Lyme Disease Therapeutics Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=76335

Key Players Operating in Global Lyme Disease Therapeutics Market

Major players operating in the global Lyme disease therapeutics market are:
-Pfizer Inc.
-Teva Pharmaceutical Industries, Ltd.
-Lupin Pharmaceuticals, Inc.
-Mylan N.V.
-Sun Pharmaceutical Industries Ltd
-GlaxoSmithKline Plc
-Valneva SE
-Sanofi
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/13/2020 -- Global Pulmonary Artery Catheter Market: Overview

Pulmonary artery carries blood from the right ventricle of the heart to the lungs for purification. Pulmonary artery catheterization is a procedure, wherein a catheter is inserted into the pulmonary artery. The flow-directed balloon-tipped pulmonary artery catheter was first discussed in 1970 and was initially developed for the management of acute myocardial infarction. It was widely used in the management of various critical illnesses and surgical procedures. Pulmonary artery catheterization is a diagnostic procedure, in which a small catheter is inserted either through neck, arm, chest, or thigh vein and moved toward the right side of the heart in order to measure the pressure of the heart. Pulmonary artery catheter is used in the diagnosis and management of numerous cardiovascular diseases such as pulmonary hypertension, cardiogenic shock, and myocardial infarction. Pulmonary catheters are also known as Swan-Ganz catheter. The standard pulmonary artery catheter has two lumens, hence Swan-Ganz, and is equipped with an inflatable balloon at the tip, which facilitates the placement of the catheter in the pulmonary artery through the flow of blood. Pulmonary artery catheterization is a feasible procedure and can be useful in understanding the cardiac physiology and pathology of the heart.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41102

Global Pulmonary Artery Catheter Market: Drivers and Restraints

The global pulmonary artery catheter market is driven by the use of pulmonary artery catheter in the preoperative, perioperative, and postoperative treatment. Above this, with rising health issues due to sedentary lifestyle and unhealthy dietary habits has increased the number of cases with cardiac complications have increased. Moreover, sedentary lifestyle and dietary habits, and increase in smoking and drinking habits are responsible for increased cardiac complications. Furthermore, rise in the geriatric population is a major factor driving the number of pulmonary artery catheterization procedures. Pulmonary artery catheterization is useful in taking standard care of all critically ill patients. However, it offers no benefits for patients with septic shocks, acute respiratory distress syndrome, and also in the routine treatment of patients undergoing high-risk of surgery.

The global pulmonary artery catheter market can be segmented based on type, application, end-user, and region. In terms of type, the market can be classified into four-lumen catheter, five-lumen catheter, six-lumen catheter, and others. Based on application, the global pulmonary artery catheter market can be bifurcated into ICU use and non-ICU use. In terms of end-user, the market can be divided into hospitals, cardiac clinics, and ambulatory surgical centers.

Request for Analysis of COVID19 Impact on Pulmonary Artery Catheter Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41102

Global Pulmonary Artery Catheter Market: Key Segments
In terms of region, the global pulmonary artery cathete
r market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The U.S. and Canada are the major markets for pulmonary artery catheters in North America due to sedentary lifestyles and rise in cardiac complications. Countries such as India, Australia, and New Zealand are the major markets for pulmonary artery catheters as lifestyle disorders are common in these countries due to unhealthy diet, lack of exercise, and sedentary life. Europe and Latin America are also promising markets due to lifestyle changes in these regions. Middle East & Africa is an emerging market for pulmonary artery catheters due to lifestyle changes.

Global Pulmonary Artery Catheter Market: Key Players

Leading players in the global pulmonary artery catheter market are Edward Lifesciences Corporation, Argon Medical Devices, Inc., ICU Medical, Inc., Biosensors International Group, VICTUS, and B. Braun Melsungen AG.

Pre book Pulmonary Artery Catheter Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=41102

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
-Customer Experience Maps
-Insights and Tools based on data-driven research
-Actionable Results to meet all the business priorities
-Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/13/2020 -- Global Sleep Aids Market: Overview

The demand within the global market for sleep aids has been rising on account of the rising incidence of insomnia across the world. A number of people complain of sleeplessness in their late fifties and early sixties, and this factor has led to the growth o the global sleep aids market. The need for sleep ads is felt across all population demographics and age groups. Several medical practitioners have approved of the utility of sleep aids in recent times. It is expected that new sleep aids would be developed by medical experts in the years. Sleep apnea devices are expected to gather popularity in the years to come. The changing lifestyles of the masses have played a vital role in the growth of the global sleeping aids market. It is expected that the growing problem of sleeplessness would prompt the medical fraternity to develop new and more efficient sleeping aids. Considering all the factors mentioned above, the global market for sleeping aids is projected to gather voluminous revenues in the years to come.

The global market for sleeping aids can be segmented on the basis of the following parameters: product type, sleep disorder, and region. The global market for sleeping aids can be deftly understood by delving into the aforementioned segments.

A report added by Transparency Market Research (TMR) on the global sleeping aids market is a representative account of the trends, opportunities, and factors pertaining to market growth. The report has been written after decoding and decrypting all the factors prevailing in the global sleeping aids market. Furthermore, the regional forces pertaining to the global sleeping aids market have also been included in the report. The leading vendors in the global sleeping aids market have also been enlisted within the report.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65582

Global Sleep Aids Market: Trends and Opportunities

The rising incidence of insomnia and sleep apnea has created commendable opportunities for growth within the global sleep aids market. Furthermore, advancements in the types of sleeping aids that developed have also aided growth. Sleep-inducing mattresses and pillows are in great popularity across the world, and this trend has directly influenced the growth of the global sleeping aids market. Narcolespy is also a rare disorder that can be controlled and treated with the help of sleep aids. Rising cases of sleep-walking and restless leg syndrome have also paved way for the inflow of voluminous revenues into the global sleep aids market. It is expected that the global sleep aids market would expand at a starry pace over the next decade.
Global Sleep Aids Market: Market Potential

The global market for sleep aids is expected to attract voluminous revenues as new investors show interest in this market. The advent of sleep laboratories and innovative medications is projected to drive demand within the global sleep aids market. Furthermore, the market for sleeping aids shall also expand alongside advancements in the field of insomnia treatment.

Request for Analysis of COVID19 Impact on Sleep Aids Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=65582

Global Sleep Aids Market: Regional Outlook

On the basis of geography, the global sleep aids market can be segmented into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. The market for sleep aids in Asia Pacific is growing at a stellar pace, majorly due to the rising workaholic population across China and Japan.
Global Sleep Aids Market: Competitive Landscape

Some of the key vendors in the global sleep aids market are DeVilbiss Healthcare LLC., SleepMed Inc., Pfizer Inc., Cadwell Laboratories Inc., and Compumedics Limited.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/13/2020 -- Manufacturers in order to reap the most out of the guidewires market are evaluating different approaches in modeling guidewires and catheters to advance techniques in endovascular interventions, notes Transparency Market Research (TMR). Medical device makers are striving to unveil guidewires that can help interventional cardiologists navigate a wide cross-section of clinical scenarios. To this end, those seeking higher stakes in the guidewires market have been extensively researching on combining various mechanical properties. Most notable of the properties they focus on comprise flexibility for easy maneuverability and hydrophilicity at the tip, in addition to shaft stiffness and retention friction, a key approach that shapes product innovations in the guidewires market.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6484

Rising Uptake in Percutaneous Coronary Interventions Churns out Sizable Global Revenues

Importantly, medical device makers in the guidewires market are aiming at helping cardiac care specialists choose the best device that fulfils the requirements of the specific clinical scenario. The growing adoption of coronary guidewires among interventional cardiologists have been propelled by rapid advances in angioplasty procedures. This is driven by rising application in percutaneous coronary interventions, world over, such as percutaneous transluminal coronary angioplasty (PTCA) and percutaneous transluminal angioplasty (PTA). The coronary guidewires segment is expected to hold the leading revenue share in the global guidewires market.
Advances being made in endovascular interventions-technology and techniques are underpinning the lucrativeness of the market. The global guidewires market is expected to garner a CAGR of 6.2% from 2017 to 2025 to climb to reach opportunities worth US$2.7 bn by 2025.

Request for Analysis of COVID19 Impact on Guidewires Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6484

Computer-based Models for Developing Guidewires Have Game-Changing Potential

Growing demand for minimally invasive interventional procedures is a key factor catalyzing advances in endovascular interventions, driving the guidewires market. Advent of computer-based models for developing guidewires has been poised with game-changing potential in the guidewires market. These models are expected to gather steam among the industry as well as the academia due to their potential in evaluating different modeling approaches comprehensively. One of the compelling business propositions in the adoption of computer modelling strategies in the guidewires market is the potential in the design optimization of instruments.
Over the past few years, the role of hybrid guidewires in endourological procedures has gathered the attention of manufacturers in the guidewires market. They are inter alia experimenting with different materials and guidewire designs.

New Catheterization Techniques Drive Product Innovations

Adoption of new catheterization techniques has also expand the potential of the guidewires market. A case in point is in cardiovascular magnetic resonance (CMR) catheterization, an emerging strategy. In this regard, nitinol guidewires have shown some potential to manufacturers to fare better in trackability, torquability, and mechanical support. This will pave way to high-performance commercial guidewires, especially in developed and developing markets.

Stricter implementation of regulations has motivated medical device makers to unveil guidewires in conformation with the prevailing regulations of the land. North America has presented several significant revenue streams to medical device makers in the global guidewires market. According to TMR, the opportunities in the market are expected to reach worth of US$662.1 by 2025-end.
The study presented here is based on a report by Transparency Market Research (TMR) titled "Guidewires Market (Product - Coronary Guidewires, Peripheral Guidewires, Neurovascular Guidewires, Urology Guidewires, Radiology Guidewires, and Gastroenterology Guidewires; End-user - Hospitals, Clinics, Ambulatory Surgical Centers, and Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025. "

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/13/2020 -- Global Research Antibodies Market: Overview

The global research antibodies market is anticipated to rise at a notable pace over the forecast period. Antibodies display exceptional physiological properties that make them sought-after for cell research.
Antibodies display other properties too. As they have the ability to attach to specific molecules, this enables specific molecules to be isolated for research. Hence, this makes for a key factor for continual research to examine the physiology and anatomy of antibodies.

The report serves to identify prevailing growth trends based on which projections made. The report constitutes most relevant data pertaining to comprehend the growth dynamics of research antibodies market. Geographical distribution of the research antibodies market and an analysis of the competitive structure are highlights of the report.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=58524

Global Research Antibodies Market: Key Trends

Currently, pharmaceutical and biopharmaceutical companies are undertaking extensive R&D activities to introduce novel products. These pursuits involve widespread use of antibodies because of their exceptional physiological properties. Therefore, research on antibodies receives a boost for their use in secondary cell research.
Pharmaceutical giants are also making hefty investments for advancement of antibodies research.

Increasing incidence of chronic diseases and life-threatening diseases such as cancer has led to extensive initiatives for advanced therapeutics. Pharmaceutical and biotechnology companies are making efforts in terms of upgrading their R&D capability and pumping money. These efforts are aimed to develop advanced therapeutics as well as personalized medicine for a gamut of chronic and fatal diseases. These factors collectively bode well for research antibodies market.

At present, stem cell research is finding keen interest of researchers and geneticists. Several studies support the efficacy of stem cell for blood cancers, blood and bone marrow diseases, immune disorders. Lately, stem cells from the umbilical cord and stem cells from the blood stream have been used to treat rare blood related diseases. Due to the dependency an antibodies for stem cell research, researchers are involved to isolate different antibodies molecules. This is aiding growth of research antibodies market.

Request for Analysis of COVID19 Impact on Research Antibodies Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=58524

Global Research Antibodies Market: Regional Analysis

The global research antibodies market is spread across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. Among them, North America holds supremacy in the overall market. The region being home to large biotechnology and biopharmaceutical companies, along with immense government aid for research are key factors behind exceptional growth of North America antibodies market.

Stringent regulations in place for manufacturers of antibodies and due adherence to these regulations accounts for high quality products from the region. This further pushes the North America research antibodies market.
On the other hand, Asia Pacific is emerging as a key region for research antibodies. Increasing R&D for antibodies and adoption of novel techniques for the production of antibodies is serving to fuel the region.

Global Research Antibodies Market: Competitive Outlook

Prominent players in the global research antibodies market include Abcam plc, Agilent Technologies, and Thermo Fisher Scientific Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
-Customer Experience Maps
-Insights and Tools based on data-driven research
-Actionable Results to meet all the business priorities
-Strategic Frameworks to boost the growth journey

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/12/2020 -- Microneedles are used for micro-projections of drugs. Microneedles are the pathways to biological membranes which can create transport pathways of micron dimensions for sampling body fluids, such as for measuring the blood glucose levels in diabetic therapy. Microneedle drug delivery system play an important role in pharmaceutical, biotechnology and medical industries. Array and microfabrication technologies are used extensively in medicine, biotechnology and pharmaceutica research. Microneedle drug delivery system promise pain-free delivery of both small and large molecular weight active pharmaceutical ingredients into the viable epidermis avoiding contact with nerve fibers and blood vessels present in the dermal layers. However, new developments in biotechnology, microfabrication technology, allow to demonstrate in vitro, ex vivo, and in vivo experiments, which is also paving the way for enhancement in the delivery of drugs.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30503

High adoption in number of safety issues that are emerging, which have short and long term implications for clinicians, patients, healthcare administrators, and regulators, growing research and development initiatives, growing demand for safer alternative to conventional hypodermic injections is the most important driving factor for microneedle drug delivery system market. According to the Centers for Disease Control and Prevention, new microneedle patch could make it easier to vaccinate people against measles and other vaccine-preventable diseases. Measles being a highly contagious virus can affect population in large number for which precautions during vaccine preparation and vaccination should be taken care. Around 20 million people are affected with measles every year and unfortunately, global coverage with the measles vaccine has been stagnant for the last few years at around 85% which is below the coverage percentage. Hence, microneedle patch are designed to administer by minimally trained workers and also to simplify storage, distribution, and disposal process. According to WHO, 2015, the number of cancer new cases is expected to rise by about 70% over the next 2 decades due to which there can be a demand of microneedle patches for the drug delivery system. Growth in technologies such as microneedle patches, rise in transdermal drug delivery applications for pain management, congestive heart failure and hormone replacement, will again fuel the overall microneedle drug delivery system market. Drug degradation, poor absorption, local irritation and variability in absorption is expected to hamper the microneedle drug delivery system market growth.

Request for Analysis of COVID19 Impact on Microneedle Drug Delivery System Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=30503

The microneedle drug delivery system market has been segmented by source type, by technology type, by application type, by end-users and by geography. In terms of technology type microneedle drug delivery system market is classified into hollow, porous, solid, and others. In terms of source type microneedle drug delivery system market is classified into silicon, metals, polymers, polysaccharides and others. In terms of application microneedle drug delivery system market is classified into cardiovascular, oncology, dermatology, neurology and others. Cardiovascular is highly growing application segment because of increasing prevalence of cardiovascular diseases and stroke globally. According to WHO, 17.5 million people died from cardiovascular diseases in 2012, representing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. In terms of end users microneedle drug delivery system market is classified into diagnostic laboratories, life sciences and research laboratories, hospitals, ambulatory surgical centers, and others.

Geographically microneedle drug delivery system market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically North America dominates the global microneedle drug delivery system market due to patient awareness with high per capita health care expenditure. Early-phase diagnosis and treatment of disease, and easy regulations for transdermal drug delivery vaccines is driving the medical biotechnology market which in turn is expected to drive the microneedle drug delivery system market in North America. Europe is the second largest market for microneedle drug delivery system as there are favorable government policies regarding health care infrastructure and awareness of contagious diseases. Asia Pacific is expected to grow at higher rate due to rising population, changing lifestyle, rising awareness between patients and increasing per capita expenditure. In addition, economic growth and improving the efficacy of cosmetic products is supporting the health care infrastructure improvement in developing countries such as India and China. Thus, all the above mentioned factors collectively support the growth of microneedle drug delivery system market for Asia Pacific region and expected to propel the market share of the segment by 2025.

The major players operating in the global microneedle drug delivery system include 3M, Vetter Pharma International GmbH, nanoBioSciences LLC, NanoPass, Microdermics Inc, Zosano Pharma Corporation, Micropoint Technologies Pte Ltd, BuBclean, MyLife Technologies, Innoture Medical Technology Limited, Phillips Plastic Corporation, Corium International, Inc., Stemedica Cell Technologies, Inc., and among others.

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/12/2020 -- Drug Eluting Beads Market: Snapshot

Expansive growth opportunities are forecasted for the drug eluting beads market across the forecast period of 2020-2030. The growing prevalence of liver diseases across the globe can bring good growth opportunities for the drug eluting beads market. The drug eluting beads therapy is primarily used for treating hyper vascularized tumors. These beads allow the continuous release of chemotherapeutic agents.

Based on type, the drug eluting beads market can be classified into Quadra Sphere, Oncozene Beads, LC Beads, and others. The drug eluting beads market, on the basis of application can be segmented into research centers, ambulatory surgical centers, specialized clinics, and hospitals.

This report provides an extensive analysis of the factors that bring good growth for the drug eluting beads market. The report also focuses on growth parameters such as competitive landscape, key trends, regional assessment, etc. The study helps the stakeholders to grasp the diverse growth factor of the drug eluting beads market conscientiously. The report also brings substantial information about the COVID-19 impact on the drug eluting beads market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78462

Drug Eluting Beads Market: Competitive Assessment

The drug eluting beads market comprises numerous players that are involved in neck-to-neck competition for gaining a prominent position. The players in the drug eluting beads market are also involved in mergers, acquisitions, joint ventures, collaborations, and partnerships for strengthening their position. These activities also ensure a rise in the growth rate for the drug eluting beads market. For instance, Varian Medical Systems acquired two product lines from Boston Scientific and Alicon for entering the drug eluting beads market.

Request for Analysis of COVID-19 Impact on Automated Cell Expansion Systems Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78462

Some well-entrenched players in the drug eluting beads market are as follows:
-Medtronic, Inc.
-ABK Biomedical, Inc.
-Merit Medical Systems
-Terumo Corporation
-CeloNova BioSciences, Inc.
-Surefire Medical, Inc.
-Biocompatibles UK Ltd.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78462

Drug Eluting Beads Market: Key Trends

The ballooning number of liver diseases around the world will prove to be an important growth generating factor for the drug eluting beads market. The growing awareness about the adoption of drug eluting beads therapy may also prove to be an important growth factor for the drug eluting beads market.

The drug eluting beads market has progressed immensely over the years. BTG, a UK-based company bagged the clearance for its DC Bead LUMI radiopaque drug eluting bead and it was the first such device available in Europe. The beads are injected into the tumors with the liver and with the help of radiopacity and allow the physician to track the beads in the tumor, thus assuring the patients of correct treatment. Many similar developments have taken place over the years and have helped in increasing the growth rate of the drug eluting beads market greatly.

Drug Eluting Beads Market: COVID-19 Impact

As the drug eluting beads market comes under the pharmaceuticals category, the production was not impacted to a large extent by the lockdown norms imposed by various countries to contain the spread of the virus. Therefore, the drug eluting beads market is minimally affected by the COVID-19 outbreak.
However, some disruptions in the supply chain logistics have resulted in dampening the growth of the drug eluting beads market. Nonetheless, the relaxations in the restrictions to put the economy back on track will help the drug eluting beads market greatly in gaining the lost growth. Thus, the post-lockdown era may prove to be an important period for the drug eluting beads market.

Drug Eluting Beads Market: Regional Perspective

The drug eluting beads market can be geographically segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. North America may gain an upper hand in terms of growth contribution to the drug eluting beads market. Novel technology adoption may serve as an important growth factor for the drug eluting beads market in the region. Europe may also gain substantial growth for the drug eluting beads market across the forecast period.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/12/2020 -- Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Overview

Heparin-induced thrombocytopenia (HIT) is one of the most common side effects of heparin therapy. A number of thrombotic conditions need heparin therapy to reduce the risk of thrombosis. Further, the therapy has showed some success in reducing the morbidity and mortality associated with thrombotic conditions. Despite the marked success of the therapy, HIT has been a major cause of morbidity, leading to amputations. The drive for the HIT treatment market stems from this trend.

Some of the key areas where the market has made strides relate to cardiac catheterization labs, intensive care units, and cardiac surgery theaters. HIT treatments usually begin after a careful clinical assessment and detection of low platelet count, while the results of functional assay and immunoassays are awaited. Some of the most common assays used by clinicians are Serotonin Release Assay, PF4 ELISA, Heparin-Induced Platelet Activation Tests, and Enzyme Immunoassay. For example, clinical diagnosis with the 4T score is done using Serotonin Release Assay and PF4 ELISA.

The epidemiology of HIT is low: 5% of patients exposed to heparin products suffer with HIT, but due to high mortality rate, the HIT treatment market is expected to make large strides.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78353

Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Competitive Analysis and Key Developments

The HIT treatment market has seen promising clinical advances on the back of constant updates in guidelines. American Society of Hematology (ASH) Guideline in 2018 has suggested various alternative anticoagulant options that clinicians can choose from. Current practice guidelines in developed nations have propelled new drugs that are thrombin inhibitors, and numerous immunoassays. This has expanded treatment options during acute HIT. Top players are aiming at unveiling new anticoagulants for enhancing healthcare team outcomes. Assay manufacturers and drug makers are leaning on reducing the risk of thromboembolic complications. Some of the well-known drugs are apixaban, rivaroxaban, dabigatran, bivalirudin, and fondaparinux.

Some of the promising players in the HIT treatment market are Celgene Corporation, Syntex S.A., Fresenius Kabi AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Mylan N.V., LEO Pharma A/S, Eisai Co., Ltd, Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., and Pfizer Inc.

Request for Analysis of COVID19 Impact on Cardiac Arrest Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78353

Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Key Trends

Growing awareness about heparin therapies made of bovine and porcine in clinical environment is a key trend bolstering the expansion of opportunities in the HIT treatment market. Advances in pathophysiology and clinical presentation and diagnosis of HIT are boosting the HIT treatment market. Progress in anticoagulant therapies has expanded new avenues. A key case in point is low-molecular-weight heparin.
Focus of players on improving the efficacy of assays has expended the clinical avenues in the HIT treatment market. PF4 ELISA is one of them that has attracted the attention of clinicians. Rising use of antigen assays for PF4 antibodies has also boosted the HIT treatment market. However, the lack of availability of advanced functional assays in hospitals has made diagnosis of HIT difficult.

Heparin-Induced Thrombocytopenia (HIT) Treatment Market: Regional Assessment
Some of the regional markets for HIT treatment can be North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, North America has witnessed considerable revenue prospects on the back of a robust lab infrastructure and rapidly rising research in anticoagulant therapies. The regional healthcare system has also seen benefits of pathophysiology. Growing awareness of the morbidity and mortality of heparin therapy in patients, particularly cardiac surgery theaters, has soured research in countries such as the U.S. Asia Pacific is expected to rise at promising potential over the forecast period of 2020 to 2030, expanding on the back of advances in assays used to detect HIT.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/12/2020 -- Global Ventilators Market: Overview

Multiple factors are leading to increase in demand for ventilators. Some of the include increased focus on intensive care and rapidly rising population of geriatric population worldwide. To compound the situation further is increase in chronic diseases. As the world sees failing health owing to lifestyle changes and demographics shift, market for ventilators chart an upward growth.
Therefore, it is easy to see why the global market for ventilators is expected to grow at an impressive CAGR (Compound Annual Growth Rate), translating to a good generation of market opportunities over the forecast period of 2019-2027.

Global Ventilators Market: Competitive Landscape

The global ventilators market is undergoing critical developments in its landscape. It is setting the tone for future competition as well as paving the road to growth over the forecast period.

The global ventilators market is slightly fragmented and key players in the market landscape include Philips Healthcare (Netherlands), ResMed (US), Medtronic (Ireland), Becton, Dickinson and Company (US), Getinge (Sweden), Draeger (Germany), Smiths Group (UK), Hamilton Medical (Switzerland), GE Healthcare (US), Fisher & Paykel (New Zealand). In order to maintain competitive edge, players enter strategic collaborations work towards product development.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73419

Global Ventilators Market: Key Trends and Drivers

The global ventilators market is set to grow on an upward trajectory, due to factors such as rise in pre-term births and rise in ageing population. Some of these are explained below

-Geriatric population is on a rise worldwide. One in six people will be in the age group 65 and above by the end of the year 2026. The situation will be more complex in North America and Europe where the ratio would be 1 in 4. To add to it, the year 2018 has already created a landmark situation. The year is historical in the sense that for the first time since the beginning of life, number of people over the age 65 outnumbered that below the age of 5. And, this is not it. There is also a rise in number pf pre-term births that increases demands for ventilator care.
-Rise in lung related problems in rising quickly. Part of the problem is change in lifestyle. As work days get longer and stress levels right, people move to unhealthy habits such as smoking and drugs. Another reason for rise in respiratory diseases is also increase in air pollution that has pulled down immune system of a whole generation. All this contributes to related diseases. This might in turn lead to increase in use of ventilators, pushing global ventilators market to more strength. What further helps the market grow is rise in disposable incomes in emerging economies, making people able to focus more on their well-being. Besides, as more women join work force, they too become an untapped opportunity ready to generate revenue for the market.

Request for Analysis of COVID19 Impact on Ventilators Market -

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73419

Global Ventilators Market: Geographical Analysis

One of the most lucrative regions in the world in terms of market growth is Asia Pacific Region Excluding Japan (APEJ). And, this trend is set to continue throughout the forecast period of 2019-2027. This significant growth in the global ventilators market owes to rise in older demographics, increase in chronic diseases, cardiovascular diseases and respiratory diseases. To add to this, the governments in this region are proactive. They are focusing their efforts and investments at improving health care outcomes.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

-Market segments and sub-segments
-Market trends and dynamics
-Supply and demand
-Market size
-Current trends/opportunities/challenges
-Competitive landscape
-Technological breakthroughs
-Value chain and stakeholder analysis
.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/09/2020 -- Transparency Market Research (TMR) has published a new report titled, 'Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027'. According to the report, the global peptide therapeutics market was valued at US$ 25.0 Bn in 2018 and is projected to expand at a CAGR of 7.9% from 2019 to 2027.

Overview

-Peptides are the combination of two or more amino acid monomers linked by amide bonds. Researchers has demonstrated that peptide are distinguished from proteins on the basis of size. As a benchmark, molecules with less than 50 amino acids are considered as peptides. Peptides act by binding to specific cell surface receptors and mimics like receptor ligands and help in treatment of diseases by acting on the cell membrane.
-The peptide therapeutics market is currently a booming one, since there has been a decline in non-peptide chemical drugs available in the market. Rise in the patent cliff has anticipated for the growth of the peptides generics market. The CMOs which provide end-to-end service to the biotech pharmaceutical companies are growing due to shift in focus of pharma companies to explore better opportunities in the peptide therapeutics market. Peptides initially had applications only in diagnostics and hormonal therapy; however, with advances in technology, peptides are now being widely applied for therapeutic applications of cancer and chronic metabolic diseases.
-North America dominate the global peptide therapeutics market in 2018 and the trend is anticipated to continue during the forecast period. Well established healthcare infrastructure, high priced peptide therapeutics drugs and favorable reimbursement policies and structure accentuate peptide therapeutics market growth in the region.
-Asia Pacific is likely to be a highly lucrative market for the peptide therapeutics market and it is expected to expand at a high CAGR during the forecast period. Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost peptide therapeutics market in Asia Pacific.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=418

Surge in Number of Cancer and Other Chronic Disease Patients to Drive Global Peptide Therapeutics Market
-Cancer is the leading cause of death globally. For instance, according to GLOBOCAN 2018, in 2018, 3,792,000 number of cancer cases in the Americas, 4,230,000 number of cases in Europe and 8,751,000 cases in Asia
-Chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. Therapeutics peptides application in cancer treatment has opened a promising avenue for future growth of peptide therapeutics market
-Besides, surge in prevalence and incidence rate of other chronic conditions such as diabetes, cardiac diseases and immune disorders, owing to increasing geriatric population is projected to propel the global peptide therapeutics market.
Cancer Segment to Dominate Peptide Therapeutics Market
-In terms of application, the global peptide therapeutics market has been segmented into cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, and renal. The cancer segment dominated the global peptide therapeutics market in 2018 and the trend is projected to continue during the forecast period. Rising mortality due to cancer has led to an increase in focus for the development of new drugs and products to combat the situation

Request for Analysis of COVID19 Impact on Cardiac Arrest Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=418

Parenteral Segment Hold a Major Share of Global Peptide Therapeutics Market
-In terms of route of administration, the global peptide therapeutics market has been classified into parenteral, oral and others.
-The parenteral segment dominated the peptide therapeutics market. The parenteral route of administration is the most common as it ensures faster and better bioavailability, faster onset time and better treatment outcomes. However, with advances in drug delivery technologies there has been a change in the trend of route of administration of therapeutic peptides.
Innovative Therapeutics Peptides to Dominate Global Peptide Therapeutics Market
-Based on type, the global peptide therapeutics market has been segmented into innovative and generic. The innovative segment dominated the global peptide therapeutics market in 2018 and the trend is projected to continue during the forecast period. Extensive R&D activities adopted by market players are expected to propel the market growth at an outstanding rate.
-However, expiry of market exclusivity of blockbuster peptide therapeutics drugs over the forecast period is likely to have an impact on the global peptide therapeutics market.

Immunopeptides Segment to exhibit Rapid Growth in Global Peptide Therapeutics Market

-In terms of molecule, Immunopeptide segment is likely to grow at rapid pace during the forecast period owing to rise in use of immunopeptides in the drugs for treatment of cancer and tumors. High prevalence of cancer and surge in incidence rate of new cancer cases is likely to drive immunopeptides market during the forecast period.
-Other peptide therapeutic drugs which are recently introduced or are in late phase of clinical trials are projected to withhold significant share of global peptide therapeutics market by the end of forecast period.
North America to Dominate Global Peptide Therapeutics Market
-In terms of region, the global peptide therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global peptide therapeutics market in 2018, followed by Europe.
-North America accounted for major share of the global peptide therapeutics market in 2018. High disease prevalence, supportive healthcare and payer infrastructure, and hub for key industry players are the major drivers of the peptide therapeutics market in the region.
-The peptide therapeutics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. Unmet medical needs, untapped nature of the market, huge investment by players, and rise in health care infrastructure are the key factors for market growth in the region
Competitive Landscape
-The global peptide therapeutics market is fragmented in terms of number of players. Key players in the global peptide therapeutics market include Amgen, Inc., Bachem Holding AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/09/2020 -- Transparency Market Research (TMR) has published a new report titled, 'Osteoporosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027'. According to the report, the global Osteoporosis Drugs market was valued at US$ 11.5 Bn in 2018 and is projected to contract at a CAGR of 0.3% from 2019 to 2027.

Overview

-Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain.
-Elevation in threat of bone cracks and introduction of new drug therapy classes are the factors that are fuelling the growth of osteoporosis drugs market. Since there is no distinct substitute available to treat osteoporosis (such as, surgery), the drugs therapy is an inevitable part of osteoporosis treatment
-Growing aging population leads for higher prevalence of osteoporosis which brings more growth opportunities for osteoporosis drugs market.
-North America dominated the global osteoporosis drugs market in 2018 and the trend is anticipated to continue during the forecast period. Higher osteoporosis incidence & prevalence rate, presence of major companies, and better diagnosis rate for the diseases are some of the major factors to dive the market in this region.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=133

Rise in prevalence of osteoporosis across the globe to Drive Market

-Higher incidence & prevalence of osteoporosis across the world is the major driver for the growth of global osteoporosis market.
-For instance, according to International Osteoporosis Foundation, Osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every 3 seconds and also it is estimated to affect 200 million women globally.
-Moreover growing aging population aged above 50 years are at the greatest risk of developing osteoporosis and related fractures due to hormonal changes. So this rise in aging population also fuelling the growth of global market.
-Development of novel approaches for the treatment of osteoporosis by new drugs and increase in awareness among people for the early diagnosis & treatment are also some of the major factors for the growth of this market.

Request for Analysis of COVID19 Impact on Osteoporosis Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=133

Bisphosphonates Segment to Dominate Market

-Based on drug class, the global osteoporosis drugs market has been divided into Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, and others.
-RANK ligand inhibitors dominated the market in 2018 due to market exclusivity of branded drugs and its efficacy to treat osteoporosis. However this segment is projected to lose its market share by the end of 2027 due to patent expiration and generics availability.
-Bisphosphonates segment is projected to dominate by the end of 2027 to first mover advantage for this class and extensive prescriptions of bisphosphonates in osteoporosis treatment.
-Sclerostin Inhibitor segment is expected to grow with higher CAGR during the forecast period owing to novel approach for of the drug for osteoporosis treatment and recent launch of product in 2019.

North America to Dominate Global Market

-In terms of region, the global osteoporosis drugs market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
-North America accounted for major share of the global osteoporosis drugs market in 2018, owing to higher prevalence of osteoporosis, recent approval of drugs in the region, and early diagnosis of disease.
-For instance, as per International Osteoporosis Foundation, osteoporosis and low bone mass are currently estimated to be a major public health threat for almost 44 million U.S. women and men aged 50 and older
-The Osteoporosis Drugs market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be attributed to growing aging population, higher demand of branded as well as generic products for osteoporosis, and increased awareness towards diagnosis & management of osteoporosis, and preference of population towards drugs with less side-effect.

Competitive Landscape
-The global Osteoporosis Drugs market is fragmented in terms of number of players. Key players in the global market include Eli Lilly and Company, Pfizer, Inc., Amgen, Inc., Merck & Co., Inc., Radius Health, Inc. , Novartis AG, Teva Pharmaceutical Industries Ltd., Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., UCB S.A., Mylan N.V., and Apotex Inc. among others

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/09/2020 -- A recent report by Transparency Market Research states that global smart medical devices market is projected to witness a substantial growth over the tenure of 2016 to 2024. The growth of the market is projected to be the result of growing health care industry. There are several government initiatives that are stimulating the medical institute to incorporate intelligent and smart medical devices that are equipped with advanced technologies. This push by the governments is the major factor that is propelling the growth of global smart medical devices market between 2016 and 2024. Moreover, the necessity to improve the healthcare infrastructure in developing countries is also a major factor that propels the growth of global smart medical devices market in the coming years.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18344

Massive Growth Potential Attracts New Players

"The global smart medical device market shall surpass the value of US$ 66.1 bn by the end of 2024, says Transparency Market Research."

The global smart medical devices market has massive growth potential as the market is expected to rise to US$ 66.1 bn from US$ 33.7 bn during the tenure of 2016 to 2024. It is because of this growth potential, new players are willing to enter the global smart medical devices market. However, the market is highly competitive due to already present prominent players. Therefore, it might be difficult for new players to establish themselves in the market.

Nevertheless, these players are incorporating strategies such as mergers and collaborations that might help them to gain sustainability in global smart medical devices market. On the other hand, the establish players are acquiring new businesses so that they can expand their operations so that can leverage more share of the global smart medical devices market.

Request for Analysis of COVID19 Impact on Cardiac Arrest Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=18344

Technologies Plays Crucial Role

"As per Transparency Market Research's analysts the global smart medical devices market is expected to witness 7.8% CAGR from 2016 to 2024."

This rate of the growth for the market is the result of technological innovations that are arriving in constant progressions. These innovations are incorporating more intelligence to the devices that are making them smarter over the period of time. Moreover, the development of new technologies like IoT and artificial intelligence, the devices can not just only monitor the health of the patients but also can predict any oncoming anomaly in the patients. This is also a major reason that is booting the growth of global smart medical devices market.
Asia Pacific Showcases Major Traction

Asia Pacific is developing rapidly in terms of healthcare services. There are various countries that are investing a fortune in developing their medical facilities. It is because of these reasons the players of global smart medical devices are focusing their operations in these countries. This as a result is propelling the dominance of Asia Pacific in global smart medical devices market from 2016 to 2024.

The global smart medical devices market is segmented on the basis of:
-Product
o Diagnostic and Monitoring Devices
o Therapeutic Device
o Injury Prevention and Rehabilitation Device
-Modality
o Portable
o Wearable
-End User
o Hospitals
o Clinics
o Home Care Settings

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/07/2020 -- Autism spectrum disorder is a disability that causes significant social, communication, and behavioral challenges. The severity of the disorder differs from person to person. It can involve mild symptoms to severe disability wherein extensive support is required. Autism spectrum disorders are lifelong developmental disabilities. The word 'spectrum' represents the range and severity of autism among different people. The cause of autism spectrum disorder is uncertain, but possible factors include discrepancies in the development of certain brain functions and the heredity. Early identification, assessment, and diagnosis is the first step toward the treatment of autism spectrum disorder.

Rise in the number of government-sponsored awareness programs for autism, innovation of new products, increase in the number of autism patients, and growing research & development activities are key factors driving the global autism spectrum disorder treatment market. The advancement in technology has results in E learning program to create awareness every corner of the world. Growing number generic pharmaceutical product for autism treatment and pipeline drugs are another key fueling factors for autism spectrum disorder treatment market. New autism medications are undergoing clinical trials, which include AT001 (Fluoxetine rapid dissolve), CNDO-201 (Trichuris suis ova), RG7314, and Syntocinon (a nasal spray). On the other hand, stricter regulations on product approval is the key restraint for the global autism spectrum disorder treatment market.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2307

The global autism spectrum disorder treatment market can be segmented based on drug class, indication, distribution channel, and geography. In terms of drug class, the market can be classified into insomnia drugs, selective serotonin reuptake inhibitors (SSRIs), anticonvulsants, antipsychotics, and others. Based on indication, the autism spectrum disorder treatment market can be divided into insomnia, epilepsy, depression, hyperactivity & inattention, and others. In terms of distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and others.

Based on geography, the global autism spectrum disorder treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global autism spectrum disorder treatment market. Factors such as new product development, rise in the number of autism patients, and growing awareness about autism among people are likely to drive the autism spectrum disorder treatment market in North America during the forecast period. According to the Center for Disease Control & Prevention (CDC), the rate of diagnosis of autism spectrum disorder in the U.S. increased from 3.57% in 2014 to 4.55% in 2016. Europe is the second-largest market for autism spectrum disorder treatment. Increasing number of awareness programs for autism and increasing research & development activities are key factors fueling the autism spectrum disorder treatment market in Europe. The Trans-European program involves universities, charities, and expert institutions in order to increase the understanding of autism in the region. The autism spectrum disorder treatment market in Asia Pacific is expected to expand at a significant pace during the forecast period, due to increasing health care expenditure, growing awareness among people, and increasing investments in research & development by key players in the region. Currently, the treatment of autism spectrum disorder in Latin America and Middle East & Africa is very low, due to lack of access to health care and lack of awareness among people about the treatment of autism spectrum disorder in these regions but likely to present immense opportunities to the autism spectrum disorder treatment market in near future. The increasing health care expenditure and rising investments by key players in these regions are projected to fuel the market in Latin America and Middle East & Africa during the forecast period.

Request for Analysis of COVID19 Impact on Autism Spectrum Disorder Treatment Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2307

Major players operating in the global autism spectrum disorder treatment market are Actavis, Inc., Curemark LLC, Janssen Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd., Pediatric BioScience, Inc., Teva Pharmaceutical Industries Ltd., Mylan Pharmaceuticals, Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb, Merck & Co., and Par Sterile Products, LLC.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

-Market segments and sub-segments
-Market trends and dynamics
-Supply and demand
-Market size
-Current trends/opportunities/challenges
-Competitive landscape
-Technological breakthroughs
-Value chain and stakeholder analysis

The regional analysis covers:
-North America (U.S. and Canada)
-Latin America (Mexico, Brazil, Peru, Chile, and others)
-Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
-Eastern Europe (Poland and Russia)
-Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
-Middle East and Africa (GCC, Southern Africa, and North Africa)

About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/07/2020 -- Transparency Market Research (TMR) has ublished a new report titled, "Dermal Fillers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026". According to the report, the global dermal fillers market was valued at US$ 2,584.9 Mn in 2017. It is projected to expand at a CAGR of 8.6% from 2018 to 2026. Expansion of the market can be attributed to technological advances leading to the development of newer hyaluronic acid dermal fillers with higher efficiency and long-lasting abilities, marketing strategies employed by market players, increasing awareness about these products on social media, and rising fad of anti-aging among people.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26816

Biodegradables is anticipated to be a lucrative segment

The report offers detailed segmentation of the global dermal fillers market. Based on product, the market has been classified into biodegradable and non-biodegradable. The biodegradable segment dominated the market in 2017. It is likely to maintain its dominance during the forecast period. Biodegradable dermal fillers usually consist of purified dermal components derived from animal, human, or bacterial sources. Expansion of the segment can be attributed to the high safety profile of these fillers and recent technological advances that offer longevity on the usage of biodegradable fillers.

Hyaluronic acid segment to expand at a robust CAGR

In terms of material, the dermal fillers market has been split into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, PMMA, fat, and others. The hyaluronic acid segment dominated the market in 2017. It is likely to maintain its dominance and expand at a high CAGR during the forecast period. More than 60% of dermal filler procedures performed globally are carried out with hyaluronic acid fillers. According to International Society of Plastic Surgeons (ISAPS), over 3,298,266 hyaluronic acid dermal filler procedures were performed annually. Additionally, technological advances have led to the development of various forms of hyaluronic acid dermal fillers, which differ according to the concentration of hyaluronic acid and the degree of crosslinking. These are known to enhance the longevity of the filler effect. These factors are anticipated to drive the market.

Request for Analysis of COVID19 Impact on Dermal Fillers Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26816

Rising fad of anti-aging driving the facial line correction treatment segment

Based on application, the dermal fillers market has been segregated into facial line correction treatment, lip enhancement, scar treatment, and others. The facial line correction treatment segment dominated the market in 2017. It is likely to continue the trend and expand at a high CAGR during the forecast period. Expansion of the segment can be attributed to the rising trend of anti-aging and increasing awareness about esthetic appearance among people. Additionally, facial line correction treatment appeals to varied age demographic, ranging from young adults to enhance their youthful features to middle-aged adults for volume restoration and older individuals to maintain age-related symptoms. Marketing strategies employed by market players, wherein celebrities promote their products, are fueling the desire among the population to mimic their favorite celebrities. This, in turn, is boosting the demand for facial line correction treatment procedures.
Dermatology clinics to expand at high CAGR

In terms of end-user, the market has been split into hospitals, ambulatory surgical centers, dermatology clinics, and others. In terms of revenue, the hospitals segment dominated the market in 2017. It is likely to maintain the trend during the forecast period. However, the dermatology clinics segment is anticipated to expand at a robust growth rate during the forecast period. Robust expansion of the segment can be attributed to the increase in dermatology consultations and surge in preference for specialist dermatologists.

Growth in Asia Pacific to be driven by Japan and India

In terms of revenue, North America dominated the global dermal fillers market in 2017. The U.S. was the major revenue generating country in the region. Expansion of the market in the country can be attributed to a rise in the number of dermal filler procedures performed annually. According to American Society of Plastic Surgeons (ASPS) over 2.3 million dermal filler procedures were performed in 2017, an increase of over 3% over 2016. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period. Expansion of the market in the region can be attributed to the increasing demand for dermal filler procedures in Japan, India, and China. Hyaluronic acid dermal filler procedures are highly common non-surgical procedures performed in various countries across Asia Pacific, including Japan, China, India, and Thailand.

Strategic acquisitions is a key strategy adopted by key players

The report provides profiles of leading players operating in the global dermal fillers market. These players include Allergan plc, Sinclair Pharma (a subsidiary of Huadong Medicine Ltd), Merz Pharma GmbH & Co. KGaA, Nestle Skin Health (Galderma), BioPlus Co., Ltd., Bioxis pharmaceuticals, SCULPT Luxury Dermal Fillers LTD, Dr. Korman Laboratories Ltd., Prollenium Medical Technologies, Advanced Aesthetic Technologies, Inc., and TEOXANE Laboratories. For instance, in 2014, Nestle acquired several dermatology brands owned by Canada-based pharmaceuticals group Valeant, which added a range of dermal fillers to the Nestle skincare business. Nestle's skincare business was established through the acquisition of Galderma. In the same year, Allergan acquired Aline hyaluronic acid (HA) thread technology from Aline Aesthetics, a wholly owned subsidiary of TauTona Group.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/07/2020 -- Global PARP Inhibitors Market: Introduction

A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.
Global PARP Inhibitors Market: Competition Landscape
Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is highly consolidated, with the presence of a small number of manufacturers. Increase in strategic collaborations and new product launches are expected to drive the global PARP inhibitors market during the forecast period.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71682

AstraZeneca

AstraZeneca is a biopharmaceutical company engaged in the discovery, manufacture, distribution, and commercialization of biopharmaceutical products. The company is a leading player in the global pharmaceutical sector. It offers various services and products in therapeutic areas such as cardiovascular and metabolic diseases; oncology; and respiratory, inflammation, and autoimmunity (RIA). Additionally, the company provides products useful in the treatment of infections, neurologic disorders, and gastrointestinal diseases. With a high focus on research and development for certain specific aspects of neurodegenerative diseases, analgesia, and psychiatry, AstraZeneca continues to collaborate with other innovative partners across industry and academia. The areas of cognitive disorders, chronic pain, and other central nervous system disorders still experience significant unmet medical needs.

Request for Analysis of COVID19 Impact on PARP Inhibitors Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71682

AbbVie Inc.

AbbVie, Inc. develops and distributes pharmaceutical products worldwide. The company offers pharmaceutical products for use in testosterone replacement therapy and the treatment of hypothyroidism and autoimmune diseases. It distributes products directly to wholesalers, government agencies, distributors, health care facilities, and specialty pharmacies worldwide. HUMIRA, a biologic therapy for the treatment of autoimmune diseases, is the company's blockbuster drug. It accounted for around 63% share of the company's sales revenues in 2014. The company sells its products in more than 170 countries across the globe.
Global PARP Inhibitors Market: Dynamics

The global PARP inhibitors market is primarily driven by increase in the rates of incidence and prevalence of cancer. In addition, increase in the adoption of PARP inhibitor drugs, growth of geriatric population, and advancements in the global health care sector are expected to boost the global PARP inhibitors market in the next few years. Furthermore, the existing market players are deploying advanced techniques to come up with innovative methods for the development of technologically advanced treatments for cancer. This is likely to propel the demand for PARP inhibitors during the forecast period. However, frequent product recalls and stringent government regulations are expected to restrain the global market in the next few years.

Increase in Incidence of Cancer Driving Global PARP Inhibitors Market

Cancer is the leading cause of death globally, after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths every year, with 70% new cancer cases expected to be reported in the next 20 years. Increase in the cancer-afflicted population is anticipated to be a key driver of the global PARP inhibitors market during the forecast period. According to a report by the Centers for Disease Control and Prevention (CDC) published in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. The number is expected to reach 25.4 million by the end of 2024. Over 60% of the world's new cancer cases occur in Asia, Africa, and South America. Nearly the same percentage of cancer deaths take place in these regions. Stomach, liver, lung, breast, and esophageal cancer are most prevalent worldwide

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/07/2020 -- Rapid infuser is a procedure/treatment which involves administration of rapid fluid used during surgical procedure. Rapid infuser device is able to deliver the fluid (human body fluid) from slow to rapid continuous flow. Rapid infuser device is prominently used in emergency situations for safe and effective treatment (when patients are admitted with hypovolemic shock or excessive blood loss). There are two prominent types of rapid infuser devices: one is driven by compressor, while the other is connected to hospital wall pressurized outlets.

Rapid infuser device is mostly used for the following surgical procedures:

-Anesthesia and intensive care unit
-Emergency unit
-Obstetrics and gynecology
-Urology division

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20582

Convenient and most effective way of delivering fluids in short span of time are the major factors deriving the global market. Moreover, use of this device in anesthesia centers have evolved over the years owing to product enhancements and application of information and sensing technology. Manufacturers in this industry are achieving innovation in patient care through integration of enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions. This has enabled clinicians and anesthesiologists to practice and deliver customized services to patients. Manufacturing companies are not only providing technically advanced products, but also value added services such as predictable patient care, access to clinical information, and thus, optimized reimbursement. Moreover, rise in incidence of chronic pulmonary diseases is accelerating market growth. According to new estimates by the World Health Organization, COPD is predicted to become the third leading cause of death by 2030. An estimated 64 million people were suffering from COPD in 2004. Moreover, approximately 13.6 million adults were diagnosed with COPD in the U.S. alone. A rise in geriatric population suffering from COPDs and asthma is further expected to accelerate the growth of the rapid infuser devices market. Increase in the number of surgeries demand development of rapid infuser devices. According to the Centers for Disease Control and Prevention (CDC), approximately 51.4 million surgical procedures were performed in the U.S. alone in 2010, which included 1.01 million cardiac catheterizations, 1.1 million endoscopic procedures of the small intestine (with or without biopsy), 499,000 endoscopic procedures of the large intestine (with or without biopsy), 395,000 coronary artery bypass grafts (CABG), 719,000 knee replacements, and 332,000 total hip replacements. It has also revealed that the number would increase in the near future. However, slow adoption rate of rapid infuser devices by hospitals is expected to hamper market growth.

Request for Analysis of COVID19 Impact on Rapid Infuser Device Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20582
Geographically, the global rapid infuser devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America contributed to the largest share of market due to growing patient awareness, favorable initiative taken by the federal government and major market players are based in the region. Asia Pacific and Latin America is identified as the emerging region for rapid infuser devices. Manufacturers have taken advantage of the presence of relatively inexpensive skilled labor in these developing regions to set up manufacturing facilities and launch affordable innovative products.
Moreover, the improving scenario for availing better health care facilities in countries such as India and China and the burgeoning medical tourism market in Asia is likely to offer immense growth opportunities in the rapid infuser devices market. Therefore, existing players are recommended to invest in emerging economies to increase their market shares.

Key players operating in the global rapid infuser devices market include 410 Medical, Inc., Belmont Instrument Corporation, Smisson-Cartledge Biomedical, LLC, and ZOLL Medical Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

-Market segments and sub-segments
-Market trends and dynamics
-Supply and demand
-Market size
-Current trends/opportunities/challenges
-Competitive landscape
-Technological breakthroughs
-Value chain and stakeholder analysis

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Albany, NY -- (SBWIRE) -- 10/06/2020 -- Transparency Market Research (TMR) has published a new report on the vitamin d testing market for the forecast period of 2019–2027. According to the report, the global vitamin D testing market was valued at ~US$ 519 Mn in 2018, and is projected to expand at a CAGR of ~6% from 2019 to 2027. Rise in the demand for vitamin D testing among people, significant repeat tests being performed, and increase in the need of performing vitamin D testing among elderly and pregnant women are contributing to the growth of the market.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33557

Rise in Number of Vitamin D Tests Performed Boosts Market Growth

-Rise in the prevalence of vitamin D deficiency, increase in the number of vitamin D tests performed, and changing lifestyles boost the growth of the global vitamin D testing market. The global vitamin D testing market is expected to expand at a CAGR of ~6% from 2019 to 2027.
-The market in Japan is likely to be driven by significant product launches by leading players, rise in the prevalence of osteoporosis, which is expected to affect over 13 million people annually, availability of reimbursements for these tests, and authority given to doctors to prescribe these tests.
-The need for vitamin D testing during pregnancy is increasing, owing to a rise in the prevalence of vitamin D deficiency in women. Deficiency of vitamin D during pregnancy can be attributed to the high requirement of vitamin D for fetal development. It is considered to be significantly common during pregnancy in high-risk groups, including vegetarians, women with limited sun exposure, and ethnic minorities, especially those with darker skin tones.
-The number of vitamin D tests performed annually has increased significantly in the past few years. Studies conducted in France indicate a dramatic increase in the number of vitamin D assay prescriptions. The number of tests performed in the country increased from 9,700 in 2008 to over 91,000 in 2013.

Request for Analysis of COVID19 Impact on Vitamin D Testing Market -
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=33557

Asia Pacific Market to Grow at Rapid Pace

-North America held a major share of the global vitamin D testing market in terms of revenue in 2018. The region is projected to dominate the global market during the forecast period. Rise in the prevalence of vitamin D deficiency, increase in prescriptions of vitamin D tests, surge in the aging population, and rise in the prevalence of vitamin D deficiency among the adult population boost the growth of the market in North America.
-Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period. Vitamin D deficiency is a public health issue in Germany. It is significantly prevalent in the adult as well as younger population. Moreover, various studies conducted in Germany indicate that, the average intake of vitamin D does not meet the recommended daily intake levels. These factors increase the number of vitamin D tests performed in the country, consequently fueling the growth of the market.
-The vitamin D testing market in Asia Pacific is expected to expand at a high CAGR of ~7% during the forecast period. Growth of the market in the region is attributed to increase in the geriatric population, rise in the prevalence of vitamin D deficiency, changing reimbursement scenario for these tests, and increase in focus of market players on strengthening their presence in developing economies.

Significant Products Launched by Market Players to Drive Market

The report provides the profiles of leading players operating in the global vitamin D testing market. These include Bio-Rad Laboratories, Inc., Abbott Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, DiaSys Diagnostic Systems GmbH, DiaSorin, bioMerieux, Siemens AG, Quest Diagnostics, and Danaher Corporation.
-DiaSorin S.p.A., one of the leading players in the vitamin D testing market, is engaged in the development, manufacture, and marketing of reagent kits for in-vitro diagnostic assays. The company offers a range of tests in the field of immunodiagnostics, and is a leading player in the vitamin D testing market in the U.S., with over 60% of the market share.
-DiaSorin focuses on expanding its CLIA tests portfolio through strategic commercial launches, globally. In 2016, the company launched the CLIA 25 OH Vitamin D test in Japan, following the announcement of reimbursements by authorities in the country. This launch made the company the first mover in launching vitamin D tests on its LIAISON analyzers. As part of this strategy, the company entered into an exclusive distribution agreement with Kyowa Medex for the distribution of its products in Japan.
-DiaSys Diagnostic Systems GmbH is a leading provider of liquid stable reagents and diagnostic solutions for clinical laboratories. It is an independent company and offers over 90 liquid-stable reagents for special and routine diagnostics, with calibrators and controls. Additionally, the company offers instruments such as partially- and fully-automated analyzers for small- and medium-sized laboratories. It also offers rapid tests and devices for point-of-care. In 2015, DiaSys Diagnostic Systems entered into an exclusive international partnership agreement with NanoSpeed Diagnostics for marketing its 25-OH Vitamin D deficiency test kit. According to the terms of the agreement, DiaSys markets the point-of-care test under its own brand, QDx, globally.
-Significant product launches and strategic partnerships are the key strategies employed by leading players to enhance their market presence. This is anticipated to fuel the growth of the global vitamin D testing market.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm